Wu Jie
Professor
Life Science and Technology
China Pharmaceutical University
China
Biography
Professor Wu Jie, Professor of Microbiology and Biochemistry in 2004. Conducted a study at the Fibrosis Research Lab at the University of Utah School of Medicine from 2008 to 2010. Jiangsu Province, "333 high-level personnel training project" third level training object. Microbiology Society members, Vaccine, Protein & Peptide Letters, "Journal of China Pharmaceutical University", "drug biotechnology", "Chinese Journal of bioengineering" peer review experts. Has long been engaged in microbial, biochemical drugs research, in recent years focused on the development of autoimmune drugs such as diabetes, has presided over or participated in a number of National Natural Science Foundation, the state "863", Jiangsu Province Science and Technology Project. Published a total of more than 50 papers, access to a number of patent licensing, access to the provincial science and technology progress prize two (based on the asparaginase peptide technology platform for the establishment of technology and innovative drug research applications).
Research Interest
development of autoimmune drugs such as diabetes
Publications
-
Yong L, Huiyong Z, Jing H, Huaqian W, Xiangbing H, Yanjun M, Xiaoyu G, Li H, Yanan Y, Rongyue C, Hao F, Jingjing L, Jie W * .Vaccination with a potent DNA vaccine targeting B- cell epitopes of hGRP induces prophylactic and therapeutic antitumor activity in vivo. Gene Ther. 2010 Apr; 17 (4): 459-68.
-
Liu Kunfeng, Liu Xiaorui, Li Guoliang, Lu Shiping, Jin Liang, Wu Jie *, Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice, Immune Lett, 2016,174: 28-36
-
Lili Shen, shiping Lu, Dongcheng Huang, Guoliang Li, Kunfeng Liu, Li Zong, Liang Jin *, Jie Wu *, Vaccination against type 1 diabetes with a novel peptide IA-2-P2 in streptozotocin- diabetic mice, Diabetes and Vascular Disease Research, 2017 May; 14 (3): 184-190.
